Vanda Pharmaceuticals | Despesa De Juros Sobre A Dívida





Despesa De Juros Sobre A Dívida Alterar Data
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.39B 85.53M 2025-09
Akebia Therapeutics 364.15M 18.56M 2025-09
Alnylam Pharmaceuticals USD 44.4M 4.15M 2025-09
Anika Therapeutics 189.44M 1.76M 2025-09
Arrowhead Research USD 22.5M 811K 2025-12
AstraZeneca USD 484M 181M 2025-12
Bristol-Myers Squibb USD 432M 48M 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
Enanta Pharmaceuticals USD 1.96M 620K 2024-12
Esperion Therapeutics USD 15.08M 1.36M 2024-09
Halozyme Therapeutics USD 4.3M 98K 2025-09
Heron Therapeutics USD 500K 900K 2024-09
Insmed USD 20.38M 863K 2025-09
J&J USD 18M 290M 2025-09
Lexicon Pharmaceuticals USD 2.21M 2.74M 2024-06
Ligand Pharmaceuticals USD 910K 243K 2025-09
Merck USD 412M 85M 2025-12
Minerva Neurosciences USD 2.31M 60K 2024-06
Moderna USD 12.14B 12.13B 2025-09
Novartis USD 281M 8M 2025-09
Pfizer USD 711M 59M 2025-12
PTC Therapeutics USD 2.64B 2.61B 2025-09
Puma Biotechnology USD 3.37M 11K 2024-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Sanofi EUR -25M 252M 2025-12
Takeda JPY 123.63B 40.49B 2025-12
Teva Pharmaceutical Industries USD 220M 17M 2025-12
Ultragenyx Pharmaceutical USD 14.15M 108K 2025-09
Vanda Pharmaceuticals 601.14M 23.61M 2025-09
Veracyte USD 2K 1000 2023-12


Vanda Pharmaceuticals Despesa De Juros Sobre A Dívida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.